Open-label phase II trial investigating the efficacy and safety of the investigational
combination of pazopanib and paclitaxel.
Phase:
Phase 2
Details
Lead Sponsor:
Heidelberg University
Collaborators:
GlaxoSmithKline Hannover Medical School Helios Klinikum Berlin-Buch Klinikum der Universitaet Muenchen, Grosshadern Medical University Innsbruck Medical University of Graz Medical University of Vienna Novartis Pharmaceuticals Universitätsklinikum Hamburg-Eppendorf Universitätsmedizin Mannheim University Hospital Dresden University Hospital, Essen